19-55391634-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001136135.2(RPL28):c.405T>C(p.Cys135Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0029 in 1,546,214 control chromosomes in the GnomAD database, including 99 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 60 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 39 hom. )
Consequence
RPL28
NM_001136135.2 synonymous
NM_001136135.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.903
Genes affected
RPL28 (HGNC:10330): (ribosomal protein L28) Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L28E family of ribosomal proteins. It is located in the cytoplasm. Variable expression of this gene in colorectal cancers compared to adjacent normal tissues has been observed, although no correlation between the level of expression and the severity of the disease has been found. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 19-55391634-T-C is Benign according to our data. Variant chr19-55391634-T-C is described in ClinVar as [Benign]. Clinvar id is 775430.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.903 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.015 (2278/152350) while in subpopulation AFR AF = 0.0514 (2136/41582). AF 95% confidence interval is 0.0496. There are 60 homozygotes in GnomAd4. There are 1117 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 2278 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPL28 | NM_000991.5 | c.*3302T>C | 3_prime_UTR_variant | Exon 5 of 5 | ENST00000344063.7 | NP_000982.2 | ||
RPL28 | NM_001136135.2 | c.405T>C | p.Cys135Cys | synonymous_variant | Exon 5 of 5 | NP_001129607.1 | ||
RPL28 | NM_001136134.1 | c.*3418T>C | 3_prime_UTR_variant | Exon 4 of 4 | NP_001129606.1 | |||
RPL28 | NM_001363697.1 | c.324+3586T>C | intron_variant | Intron 4 of 4 | NP_001350626.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPL28 | ENST00000344063.7 | c.*3302T>C | 3_prime_UTR_variant | Exon 5 of 5 | 1 | NM_000991.5 | ENSP00000342787.3 | |||
RPL28 | ENST00000426763.3 | n.5154T>C | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
RPL28 | ENST00000558815.5 | c.405T>C | p.Cys135Cys | synonymous_variant | Exon 5 of 5 | 2 | ENSP00000452909.1 | |||
RPL28 | ENST00000560055.5 | c.324+3586T>C | intron_variant | Intron 4 of 4 | 3 | ENSP00000452763.1 |
Frequencies
GnomAD3 genomes AF: 0.0149 AC: 2269AN: 152232Hom.: 58 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2269
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00370 AC: 561AN: 151642 AF XY: 0.00278 show subpopulations
GnomAD2 exomes
AF:
AC:
561
AN:
151642
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00159 AC: 2211AN: 1393864Hom.: 39 Cov.: 27 AF XY: 0.00141 AC XY: 972AN XY: 687660 show subpopulations
GnomAD4 exome
AF:
AC:
2211
AN:
1393864
Hom.:
Cov.:
27
AF XY:
AC XY:
972
AN XY:
687660
Gnomad4 AFR exome
AF:
AC:
1584
AN:
31448
Gnomad4 AMR exome
AF:
AC:
142
AN:
35680
Gnomad4 ASJ exome
AF:
AC:
0
AN:
25118
Gnomad4 EAS exome
AF:
AC:
0
AN:
35692
Gnomad4 SAS exome
AF:
AC:
20
AN:
79110
Gnomad4 FIN exome
AF:
AC:
0
AN:
49272
Gnomad4 NFE exome
AF:
AC:
186
AN:
1074058
Gnomad4 Remaining exome
AF:
AC:
247
AN:
57806
Heterozygous variant carriers
0
101
203
304
406
507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0150 AC: 2278AN: 152350Hom.: 60 Cov.: 33 AF XY: 0.0150 AC XY: 1117AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
2278
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
1117
AN XY:
74500
Gnomad4 AFR
AF:
AC:
0.0513684
AN:
0.0513684
Gnomad4 AMR
AF:
AC:
0.00562018
AN:
0.00562018
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207039
AN:
0.000207039
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000352786
AN:
0.000352786
Gnomad4 OTH
AF:
AC:
0.0137311
AN:
0.0137311
Heterozygous variant carriers
0
114
228
342
456
570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Apr 10, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at